The Role of the Serotonin Pathway of Tryptophan Metabolism in the Development of Neuroinflammation in Alzheimer's Disease

被引:0
|
作者
Fomin, A. S. [1 ]
Sergeeva, S. P. [2 ]
机构
[1] Sechenov First Moscow State Med Univ Sechenov Univ, Moscow, Russia
[2] Pirogov Russian Natl Res Med Univ, Moscow, Russia
关键词
Alzheimer's disease; tryptophan; melatonin; serotonin;
D O I
10.1134/S207905702460023X
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Despite the fact that more than 90% of tryptophan is metabolized via the kynurenine pathway, the serotonin pathway is of great importance for the functioning of the central nervous system. The main products of this pathway are serotonin and melatonin. They provide maintenance of the sleep-wake mode, modulation of oxidative stress activity, apoptosis of neurons and glial elements, regeneration and neuroinflammation. In the pathogenesis of Alzheimer's disease, neuroinflammation plays one of the main roles. Melatonin and serotonin, being modulators of its intensity, as well as an important component of neurochemical interactions that provide cognitive functions, can be considered as targets for preventive and therapeutic effects.
引用
收藏
页码:123 / 129
页数:7
相关论文
共 50 条
  • [41] The Role of Exosomes as Mediators of Neuroinflammation in the Pathogenesis and Treatment of Alzheimer's Disease
    Weng, Shiting
    Lai, Qi-Lun
    Wang, Junjun
    Zhuang, Liying
    Cheng, Lin
    Mo, Yejia
    Liu, Lu
    Zhao, Zexian
    Zhang, Ying
    Qiao, Song
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [42] Neuroinflammation and Neuroimmunomodulation in Alzheimer’s Disease
    Hong Y.
    Xu J.
    Hu Y.
    Li L.
    Dong Z.
    Zhu T.-K.
    Wei Y.-Q.
    Current Pharmacology Reports, 2018, 4 (5) : 408 - 413
  • [43] Neuroinflammation as motor of Alzheimer's disease
    Castro-Gomez, Sergio
    Binder, Julius
    Heneka, Michael T.
    NERVENARZT, 2019, 90 (09): : 898 - 906
  • [44] Cytokines in neuroinflammation and Alzheimer's disease
    Cacquevel, M
    Lebeurrier, N
    Chéenne, S
    Vivien, D
    CURRENT DRUG TARGETS, 2004, 5 (06) : 529 - 534
  • [45] Targeting neuroinflammation in Alzheimer's disease
    Bronzuoli, Maria Rosanna
    Iacomino, Aniello
    Steardo, Luca
    Scuderi, Caterina
    JOURNAL OF INFLAMMATION RESEARCH, 2016, 9 : 199 - 208
  • [46] Iron, neuroinflammation, and Alzheimer's disease
    Ong, WY
    Farooqui, AA
    JOURNAL OF ALZHEIMERS DISEASE, 2005, 8 (02) : 183 - 200
  • [47] Astrocytes and neuroinflammation in Alzheimer's disease
    Phillips, Emma C.
    Croft, Cara L.
    Kurbatskaya, Ksenia
    O'Neill, Michael J.
    Hutton, Michael L.
    Hanger, Diane P.
    Garwood, Claire J.
    Noble, Wendy
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2014, 42 : 1321 - 1325
  • [48] Drug Development for Alzheimer's Disease: Microglia Induced Neuroinflammation as a Target?
    Dong, Yuan
    Li, Xiaoheng
    Cheng, Jinbo
    Hou, Lin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (03)
  • [49] Role for cell death pathway in Alzheimer's disease
    Sirkis, Daniel W.
    Yokoyama, Jennifer S.
    SCIENCE, 2023, 381 (6663) : 1156 - 1157
  • [50] Role of cholesterol metabolism in the pathogenesis of Alzheimer's disease
    Allinquant, Bernadette
    Clamagirand, Christine
    Potier, Marie-Claude
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2014, 17 (04): : 319 - 323